SARS-CoV-2 Flashcards

1
Q

What are some historical events in the timeline of Coronaviruses?

A

1931 = first coronavirus discovered

1966 = discovery of HCoV-229E

1967 = discovery of HCoV-OC43

1986 = polyprotein processing

1987 = full genome sequenced

1992 = targeted recombination

2000 = reverse genetics

2002 = SARS-CoV PANDEMIC + EM of memb. vesicle

2004 = discovery of HCoV-NL63

2005 = discovery of HCoV-HKU1

2012 = MERS-CoV PANDEMIC

2019 = SARS-CoV-2 PANDEMIC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the Coronavirus family?

A

SARS-CoV-2
= virus that causes covid-19
= belongs to the coronaviridae family

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Compare MERS, SARS, Covid-19

A

MERS
= 2521 cases
= 866 total deaths (infections still occurring)
= 35% case fatality rate

SARS (SARS-CoV-1)
= 80098 cases
= 774 total deaths (epidemic ended)
= ~1% case fatality

= spillover reservoir unknown: civet cats
(cull to break the chain)
= most transmission occurred in hospital setting (hubs)
= no transmission until 24-36h after symptoms, lack of asymptomatic cases
(contract tracing effective)

Covid-19 (SARS-CoV-2)
= spillover reservoir unknown
= widespread community transmission
= possible abundant asymptomatic / mild cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the role of bats + intermediate hosts?

A

= >500 CoVs been identified in bats in china
(undiscovered could reach >5000)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the SARS-CoV-2 genome?

A

Genome
= single-stranded
= non-segmented
= positive sense
= ~30kb long genome

Encodes for 27 genes which are either:

Structural
= constitute the virion
= include S,E,M,N

Non-structural
= not structural components of virion
= include NSP1, NSP2, NSP3, NSP14 etc.

Accessory proteins
= produced only in infected cells
= includes ORF3b, ORF6, ORF7a etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What kind of replication occurs?

A

= discontinuous replication

= undergo discontinuous transcription

= leading to high recombination rates

= error rate for RNA replication is reduced by proof reading enzyme ExoN (NSP14)
(RNA photocopying)

= this is a basis for diagnostics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the structure and function of the coronavirus virion and viral proteins?

A

= ~125 nm diameter
= enveloped viruses
= numerous surface-projected club-like spikes

S protein (spike)
= entry of SARS-CoV-2 into cells
= host tropism
= protective immune responses (vaccines)
= virulence (severity of disease)

N protein (nucleocapsid)
= component of nucleocapsid
= virus transcription efficiency
= protective immune responses (vaccines)

M protein (membrane)
= most abundant amongst structural proteins
= assembly of virus particles

E protein (envelope)
= smallest amongst all the structural proteins
= virus assembly and release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the gate to entry in the cell?

A

= Cleavability (and receptor interaction)

= different variants enter differently

Delta variant
= binds to specific receptor protein: ACE2
= then uses spike protein to fuse with cell membrane
= TMPRSS2 involved to cleave the spike protein
= virus gains entry into cell

Omicron variant
= virus internalised into endosome
= fuses with lysosome to form endolysosome
= virus can be cleaved by cathepsin enzymes = which activate viral spike protein and facilitate fusion with endolysosomal membrane
= leads to release of viral RNA into cytoplasm + infection of host cell
(mutation - N856Y increases susceptibility of virus to cathepsin cleavage)

Mutations in the RBD of Spike protein determine:
= new variants
= transmissibility
= virulence
= vaccine escape

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the SARS-CoV-2 replication cycle?

A
  1. Attachment
    = virus attached to host cells by binding to ACE2 receptor on surface of human cells
  2. Entry
    = virus enters host cell by membrane fusion / endocytosis
    = viral genome released into cytoplasm
  3. Translation
    = viral RNA is translated into viral proteins by host cell machinery
  4. Replication
    = viral RNA replicated by viral RNA-dependent RNA polymerase
    = producing more copies of viral RNA
  5. Assembly
    = viral proteins and viral RNA come together to form new virus particles
  6. Release
    = new virus particles are released from the infected cell
    = either by budding or lysis of host cell

EXTRA READING
= virus also manipulated host cell’s immune system to evade detection and destruction
= replication cycle can take several hours
= infected cells can release thousands of new virus particles = spread of COVID-19

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the innate immunity against SARS-CoV-2?

A

Omicron
= upper respiratory
= less pathogenic
= BUT spread more

Delta
= deep in the lung cavity
= spread less but more pathogenic

Cytokine Storm
1. coronavirus infectes lung cells

  1. immune cells, including macrophages, identify the virus and produce cytokines
  2. cytokines attract more immune cells (e.g. WBCs) which then produce more cytokines
    (cycle of inflammation - damages the lungs)
  3. damage can occur through formation of fibrin
  4. weakened blood vessels allow fluid to seep in and fill lung cavities = leading to respiratory failure

(Dexamathasone = steroid, reduces cytokine storm, calms immune system without damaging cells)

EXTRA READING
= also physical barriers, PRRs, NK cells, phagocytic cells, interferons, complement system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What adaptive immunity aspects are involved in long-term protection against SARS-CoV-2?

A

Antibodies (from B cells):
= important in almost all currently licensed human COVID vaccines
= most recovered COVID patients have antibodies within 1-3 wks
= severe disease correlates with higher levels of antibodies

CD4+ T helper cells:
= critical for antibody responses
= protection independent on antibodies in SARS
= cross reactive immunity against pan-coronaviruses

CD8+ T killer cells:
= important in many viral infections
= may prevent re-infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What anatomy is involved in adaptive immunity against SARS-CoV-2?

A

= mostly immunity (antibodies) measured in blood

= local sites of infection / portals of entry are important

= local immunity in lungs, nasal passages, oral cavity and salivary glands can consist of:
- CD8+ T cells
- CD4+ T cells
- IgG antibodies
- IgA antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What mechanisms of protective immunity against covid-19 are there?

A

Simplest vaccine
= high level, long lasting + neutralising antibodies

= substantial protective contributions of T cell immunity against COVID-19

= hospitalisation correlate with the decent combination of antibodies, CD4 and CD8 T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the transmission of SARS-CoV-2?

A

Droplets

Aerosols

Smear Infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are some measures to control transmission of SARS-CoV-2?

A

= masks
(N95 - better for aerosols)
(surgical - better for droplet)
(cotton - not really useful)
= due to filtration of different particle sizes

(distance of seperation required discovered using experiments with donor, indirect recipient and controlled airflow)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are some different approaches to SARS-CoV-2 Vaccine development?

A

Live attenuated

Whole inactivated

RNA
(Pfizer, moderna)

DNA

Recombinant subunits
(Novavax)

Recombinant viral vectors
(AstraZeneca, oxford, J + J)

17
Q

What are some other SARS-CoV-2 treatment strategies?

A

Monoclonal antibody / convalescent plasma for ACE-2
= prevent the virus into the host cell

Camostat mesylate
= prevent SARS-CoV-2 getting into cell by acting on TMPRSS2

Lopinavir-Ritonavir (HIV)
= inhibition of protease activity of SARS-CoV-2

Ribavirin (HCV)
= may inhibit mRNA capping

RNA synthesis inhibitors
= inhibits SARS-CoV-2 RNA synthesis and replication

Chloroquine group
= interfere with the release of progeny from infected host cells